Purpose
The NRG NCORP Cancer Prevention and Control (CPC) Committee prioritizes interventional studies designed to improve the symptom burden from cancer and its treatment, or to prevent cancer or morbidity from cancer and its treatment. Research priorities and focus areas include: improving neurocognition; reducing gender-specific symptoms (lymphedema, sexual dysfunction, etc.); behavioral interventions to mitigate symptoms or cancer risk; therapeutic delivery modifications and/or agents to improve symptoms, quality of life, and cost-effectiveness; and, prevention through optimal screening, risk reduction, or chemoprevention.
The goal of the NRG NCORP CPC Committee is to generate high impact research that prevents and finds cancers early and improves the health of cancer survivors. We accomplish this through interdisciplinary team science and strong collaboration with NRG’s Health Disparity and Disease-Site Committees. As such, our committee membership is intentionally diverse (discipline; research focus; MD, PhD, RN, APP, patient advocates; academic and community; all career levels) with an important focus in mentoring the next generation of CPC clinician scientists. Committee members have the opportunity to serve as liaisons to the Disease-site Committees, review new concepts and to become co-investigators on developing trials.
This committee meets monthly.